2010-09-17 |
2010-09-17 |
A
Achat
|
Garone Michael
Secretary, CFO
Dirigeant
|
60 000
+150.0%
1,08
64 800 USD
|
60 000
+150.0%
|
1,08
|
64 800 USD
|
|
2010-09-17 |
2010-09-15 |
A
Achat
|
Garone Michael
Secretary, CFO
Dirigeant
|
5 000
+14.3%
1,07
5 350 USD
|
5 000
+14.3%
|
1,07
|
5 350 USD
|
|
2010-09-17 |
2010-09-15 |
A
Achat
|
Garone Michael
Secretary, CFO
Dirigeant
|
500
+1.4%
1,08
538 USD
|
500
+1.4%
|
1,08
|
538 USD
|
|
2010-09-17 |
2010-09-15 |
A
Achat
|
Garone Michael
Secretary, CFO
Dirigeant
|
2 500
+7.8%
1,08
2 700 USD
|
2 500
+7.8%
|
1,08
|
2 700 USD
|
|
2010-09-17 |
2010-09-15 |
A
Achat
|
Garone Michael
Secretary, CFO
Dirigeant
|
32 000
+inf%
1,10
35 200 USD
|
32 000
+inf%
|
1,10
|
35 200 USD
|
|
2009-12-10 |
2009-12-09 |
V
Vente
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Dirigeant
|
7 000
-25.5%
0,70
4 900 USD
|
7 000
-25.5%
|
0,70
|
4 900 USD
|
|
2009-12-10 |
2009-12-09 |
V
Vente
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Dirigeant
|
5 000
-15.4%
0,70
3 500 USD
|
5 000
-15.4%
|
0,70
|
3 500 USD
|
|
2009-12-10 |
2009-12-09 |
V
Vente
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Dirigeant
|
5 000
-13.3%
0,71
3 525 USD
|
5 000
-13.3%
|
0,71
|
3 525 USD
|
|
2009-12-10 |
2009-12-09 |
V
Vente
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Dirigeant
|
5 000
-11.8%
0,72
3 600 USD
|
5 000
-11.8%
|
0,72
|
3 600 USD
|
|
2009-12-10 |
2009-12-09 |
V
Vente
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Dirigeant
|
7 500
-15.0%
0,74
5 550 USD
|
7 500
-15.0%
|
0,74
|
5 550 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
14 744
+41.8%
4,20
61 925 USD
|
14 744
+41.8%
|
4,20
|
61 925 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
200
+0.6%
4,19
838 USD
|
200
+0.6%
|
4,19
|
838 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
100
+0.3%
4,19
419 USD
|
100
+0.3%
|
4,19
|
419 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
100
+0.3%
4,18
418 USD
|
100
+0.3%
|
4,18
|
418 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
737
+2.2%
4,17
3 073 USD
|
737
+2.2%
|
4,17
|
3 073 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
500
+1.5%
4,16
2 080 USD
|
500
+1.5%
|
4,16
|
2 080 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
6 000
+21.7%
4,15
24 900 USD
|
6 000
+21.7%
|
4,15
|
24 900 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
4 400
+18.9%
4,14
18 216 USD
|
4 400
+18.9%
|
4,14
|
18 216 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
300
+1.3%
4,13
1 239 USD
|
300
+1.3%
|
4,13
|
1 239 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
100
+0.4%
4,11
411 USD
|
100
+0.4%
|
4,11
|
411 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
400
+1.8%
4,10
1 640 USD
|
400
+1.8%
|
4,10
|
1 640 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
319
+1.4%
4,09
1 305 USD
|
319
+1.4%
|
4,09
|
1 305 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
200
+0.9%
4,08
816 USD
|
200
+0.9%
|
4,08
|
816 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
300
+1.4%
4,07
1 221 USD
|
300
+1.4%
|
4,07
|
1 221 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
1 600
+8.0%
4,06
6 496 USD
|
1 600
+8.0%
|
4,06
|
6 496 USD
|
|
2008-08-20 |
2008-08-18 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
17 781
+801.3%
4,20
74 680 USD
|
17 781
+801.3%
|
4,20
|
74 680 USD
|
|
2008-08-20 |
2008-08-18 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
719
+47.9%
4,19
3 013 USD
|
719
+47.9%
|
4,19
|
3 013 USD
|
|
2008-08-20 |
2008-08-18 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
1 100
+275.0%
4,18
4 598 USD
|
1 100
+275.0%
|
4,18
|
4 598 USD
|
|
2008-08-20 |
2008-08-18 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
400
+inf%
4,17
1 668 USD
|
400
+inf%
|
4,17
|
1 668 USD
|
|
2008-05-13 |
2008-05-09 |
A
Achat
|
Novinski Michael V
President and CEO
Administrateur exécutif
|
1 300
+3.4%
1,69
2 197 USD
|
1 300
+3.4%
|
1,69
|
2 197 USD
|
|
2008-05-13 |
2008-05-09 |
A
Achat
|
Novinski Michael V
President and CEO
Administrateur exécutif
|
3 900
+11.2%
1,68
6 552 USD
|
3 900
+11.2%
|
1,68
|
6 552 USD
|
|
2008-05-13 |
2008-05-09 |
A
Achat
|
Novinski Michael V
President and CEO
Administrateur exécutif
|
4 700
+15.6%
1,65
7 755 USD
|
4 700
+15.6%
|
1,65
|
7 755 USD
|
|
2008-05-13 |
2008-05-09 |
A
Achat
|
Novinski Michael V
President and CEO
Administrateur exécutif
|
2 200
+7.9%
1,60
3 520 USD
|
2 200
+7.9%
|
1,60
|
3 520 USD
|
|
2008-05-13 |
2008-05-09 |
A
Achat
|
Novinski Michael V
President and CEO
Administrateur exécutif
|
1 968
+7.6%
1,60
3 149 USD
|
1 968
+7.6%
|
1,60
|
3 149 USD
|
|
2008-05-13 |
2008-05-09 |
A
Achat
|
Novinski Michael V
President and CEO
Administrateur exécutif
|
800
+3.2%
1,59
1 272 USD
|
800
+3.2%
|
1,59
|
1 272 USD
|
|
2008-05-13 |
2008-05-09 |
A
Achat
|
Novinski Michael V
President and CEO
Administrateur exécutif
|
132
+0.5%
1,58
209 USD
|
132
+0.5%
|
1,58
|
209 USD
|
|
2007-12-31 |
2007-12-31 |
A
Achat
|
Novinski Michael V
President and CEO
Dirigeant
|
5 000
+25.0%
2,67
13 336 USD
|
5 000
+25.0%
|
2,67
|
13 336 USD
|
|
2007-08-31 |
2007-08-22 |
A
Achat
|
GOLDBERG MICHAEL M
Administrateur non-exécutif
|
99 246
0,00
0 USD
|
99 246
|
0,00
|
0 USD
|
|
2007-08-24 |
2007-08-22 |
A
Achat
|
RACHESKY MARK H MD
Administrateur non-exécutif
Actionnaire important
|
129 390
0,00
0 USD
|
129 390
|
0,00
|
0 USD
|
|
2006-05-11 |
2006-05-09 |
A
Achat
|
RACHESKY MARK H MD
Administrateur non-exécutif
Actionnaire important
|
473 577
+inf%
8,26
3 911 746 USD
|
473 577
+inf%
|
8,26
|
3 911 746 USD
|
|
2006-05-11 |
2006-05-09 |
A
Achat
|
RACHESKY MARK H MD
Administrateur non-exécutif
Actionnaire important
|
187 979
+inf%
8,26
1 552 707 USD
|
187 979
+inf%
|
8,26
|
1 552 707 USD
|
|
2006-05-11 |
2006-05-09 |
A
Achat
|
RACHESKY MARK H MD
Administrateur non-exécutif
Actionnaire important
|
31 554
+8.0%
8,26
260 636 USD
|
31 554
+8.0%
|
8,26
|
260 636 USD
|
|
2006-05-11 |
2006-05-09 |
A
Achat
|
RACHESKY MARK H MD
Administrateur non-exécutif
Actionnaire important
|
266 890
+9.3%
8,26
2 204 511 USD
|
266 890
+9.3%
|
8,26
|
2 204 511 USD
|
|
2004-09-21 |
2004-09-16 |
V
Vente
|
BLACK MICHAEL E
Administrateur non-exécutif
|
500
-20.6%
3,61
1 805 USD
|
500
-20.6%
|
3,61
|
1 805 USD
|
|
2004-05-11 |
2004-05-07 |
V
Vente
|
BENDER LEWIS H
Sr. VP Business Development
|
5 000
-26.4%
5,18
25 915 USD
|
5 000
-26.4%
|
5,18
|
25 915 USD
|
|
2004-05-11 |
2004-05-07 |
V
Vente
|
BENDER LEWIS H
Sr. VP Business Development
|
103
-0.7%
5,18
534 USD
|
103
-0.7%
|
5,18
|
534 USD
|
|